Moreover, day-to-day fasting SMBG variability was also found to be associated with the risk of overall symptomatic, nocturnal symptomatic and severe hypoglycemia in insulin-treated patients with diabetes [68]. The gene discussed is INS; the disease is Hypoglycemia.